QHSLab Q1 2023 revenue $352,799, up 32% sequentially; gross margin 53.1%

QHSLab, Inc.

2024-Q1 EPS reported -$0.02 revenue$352,799

Net operating loss narrowed 17.1% to $120,758 from $145,701 in Q4 2022.
Digital Medicine ISP service revenue surged 324% sequentially to $34,467.
Allergy segment revenue increased 20% sequentially to $49,537.
Management expects Digital Medicine ISP revenue to grow ~100% in Q2 2023.
Gross margin target of +500 bps expansion for fiscal 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.